MiniMed Group, Inc. income statement MMED

In Q1 of fiscal 2027, the quarter ended Jul 31, 2026, MiniMed Group, Inc. reported revenue of $843.0 million. Net income was $0. Operating income came to $5.0 million, an operating margin of 0.6%. Diluted earnings per share were $0.00.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Jul 31, 2026
Q1 FY2027
Jul 31, 2026
Q4 FY2026
Apr 24, 2026
Q3 FY2026
Jan 23, 2026
Revenue
—
843
837
790
Cost of revenue
—
378
357
428
Gross profit
—
465
480
362
Selling, general and administrative
—
312
299
309
Other operating income (expense)
—
-36
-168
-45
Restructuring and impairment
—
2
—
—
Operating income
—
5
-93
-100
Other non-operating income (expense)
—
0
1
0
Pretax income
—
4
-92
-99
Income tax
—
4
93
12
Net income
—
0
-185
-119
Basic EPS
—
0.00
-0.69
-0.47
Diluted EPS
—
0.00
-0.69
-0.47
Weighted average shares, basic
—
281
268
253
Weighted average shares, diluted
—
281
268
253
Other measures
Depreciation and amortization
—
41
39
117
EBITDA
—
46
-54
17
Margins
Gross margin
—
55.16%
57.35%
45.82%
Operating margin
—
0.59%
-11.11%
-12.66%
Pretax margin
—
0.47%
-10.99%
-12.53%
Profit margin
—
0.00%
-22.10%
-15.06%
EBITDA margin
—
5.46%
-6.45%
2.15%
Effective tax rate
—
100.00%
—
—
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
MMED (Nasdaq), MMEDV (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Northridge, CA
SEC filer status
Non-accelerated filer
SEC CIK
2062583
Former names
MDT Sub Holdings, Inc. (until May 30, 2025)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.